447.9500 -9.45 (-2.07%)
NSE Jan 13, 2026 15:31 PM
Volume: 1.1M
 

447.95
-2.07%
ICICI Securities Limited
Suven’s rapid ascendance in the CDMO space has been remarkable. It has journeyed from being a small molecule-focused CDMO to achieving eminence as one of the few CDMOs in India that offers contract manufacturing of oligonucleotides and ADCs.
Cohance Lifesciences has lost -16.40% in the last 1 Month
More from Cohance Lifesciences Ltd.
Recommended